Calbindin D-28k and parvalbumin immunoreactivity in the frontal cortex in patients with frontal lobe dementia of non-Alzheimer type associated with amyotrophic lateral sclerosis
- PMID: 8459241
- PMCID: PMC1014857
- DOI: 10.1136/jnnp.56.3.257
Calbindin D-28k and parvalbumin immunoreactivity in the frontal cortex in patients with frontal lobe dementia of non-Alzheimer type associated with amyotrophic lateral sclerosis
Abstract
The morphology and distribution of local-circuit neurons (interneurons) were examined, by calbindin D-28k and parvalbumin immunocytochemistry, in the frontal cortex (area 8) in two patients with frontal lobe dementia of non-Alzheimer type associated with classical amyotrophic lateral sclerosis (ALS), and in seven normal cases. The density of calbindin D-28k immunoreactive cells was dramatically reduced in ALS patients, but the density of parvalbumin-immunoreactive neurons was preserved. Decreased density of calbindin D-28k-immunoreactive neurons, which are mainly located in the upper cortical layers, may interfere with the normal processing of cortico-cortical connections, whereas integrity of parvalbumin-immunoreactive cells may be associated with the preservation of the major inhibitory intracortical circuits in patients with frontal lobe dementia.
Similar articles
-
Anomalous inhibitory circuits in cortical tubers of human tuberous sclerosis complex associated with refractory epilepsy: aberrant expression of parvalbumin and calbindin-D28k in dysplastic cortex.J Child Neurol. 2006 Dec;21(12):1058-63. doi: 10.1177/7010.2006.00242. J Child Neurol. 2006. PMID: 17156698
-
Calbindin D-28k and parvalbumin in the rat nervous system.Neuroscience. 1990;35(2):375-475. doi: 10.1016/0306-4522(90)90091-h. Neuroscience. 1990. PMID: 2199841
-
Parvalbumin and calbindin D-28k immunoreactivity in transgenic mice with a G93A mutant SOD1 gene.Brain Res. 2006 Apr 14;1083(1):196-203. doi: 10.1016/j.brainres.2006.01.129. Epub 2006 Mar 20. Brain Res. 2006. PMID: 16546142
-
Frontal lobe degeneration of non-Alzheimer type. Structural characteristics, diagnostic criteria and relation to other frontotemporal dementias.Acta Neurol Scand Suppl. 1996;168:28-30. Acta Neurol Scand Suppl. 1996. PMID: 8997416 Review.
-
Amyotrophic lateral sclerosis and frontal lobe dementia in Alzheimer's disease. Case report and review of the literature.Eur Neurol. 1993;33(4):320-4. doi: 10.1159/000116962. Eur Neurol. 1993. PMID: 8348920 Review.
Cited by
-
Dementia lacking distinctive histopathology: clinicopathological evaluation of 32 cases.Acta Neuropathol. 1995;89(4):346-55. doi: 10.1007/BF00309628. Acta Neuropathol. 1995. PMID: 7610766
-
Investigating perturbed pathway modules from gene expression data via structural equation models.BMC Bioinformatics. 2014 May 6;15:132. doi: 10.1186/1471-2105-15-132. BMC Bioinformatics. 2014. PMID: 24885496 Free PMC article.
-
A comparative perspective on minicolumns and inhibitory GABAergic interneurons in the neocortex.Front Neuroanat. 2010 Feb 5;4:3. doi: 10.3389/neuro.05.003.2010. eCollection 2010. Front Neuroanat. 2010. PMID: 20161991 Free PMC article.
-
Preconditioning, induced by sub-toxic dose of the neurotoxin L-BMAA, delays ALS progression in mice and prevents Na+/Ca2+ exchanger 3 downregulation.Cell Death Dis. 2018 Feb 12;9(2):206. doi: 10.1038/s41419-017-0227-9. Cell Death Dis. 2018. PMID: 29434186 Free PMC article.
-
Hippocampal interneuron loss in an APP/PS1 double mutant mouse and in Alzheimer's disease.Brain Struct Funct. 2010 Mar;214(2-3):145-60. doi: 10.1007/s00429-010-0242-4. Epub 2010 Mar 7. Brain Struct Funct. 2010. PMID: 20213270 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous